Manufacturing remains big challenge for cell and gene therapy industry Science Advisory Board spoke with Eric Blair, chief commercial officer for Andelyn Biosciences, at last week’s 2022 Cell & Gene Meeting on the Mesa about the challenges of manufacturing to meet growing demand in the cell and gene therapy industry.Read More
Akadeum looks to advance the cell separation process with microbubbles Microbubble technology offers researchers the ability to perform cell separation without a column or magnet, generating higher yield and faster turnaround times, according to Akadeum Life Sciences CEO Brandon McNaughton who spoke with ScienceBoard.net about the company's technology.Read More
Video from AACC: Fluxergy's multimodal testing platform Fluxergy president and co-founder Tej Patel sat down with us at AACC 2022 and discussed the company’s multimodal, multiomic platform that enables doctors to perform different kinds of tests, including reverse transcription polymerase chain reaction and serology tests, using a single instrument and software program.Read More
Video from AACC: First impressions, Day 1 Reflecting on highlights from the LabPulse.com and ScienceBoard.net team for Day 1, Kalorama Information's Bruce Carlson compares AACC 2022 with previous meetings.Read More
Video from AACC: PerkinElmer on diagnostics, acquisitions Greg Stock, general manager of PerkinElmer’s Euroimmun business, discussed products and technologies on display at AACC 2022, as well as the integration of acquired companies such as Oxford Immunotec.Read More